Try our Advanced Search for more refined results

Purdue Pharma L.P.

Track this case

Case overview

Case Number:

7:19-bk-23649

Court:

New York Southern

Nature of Suit:

Firms

Companies

Government Agencies

Sectors & Industries:

  1. April 27, 2021

    Newborn Opioid Victim Group Says Purdue Docs Lack Info

    A group representing the interests of victims of neonatal abstinence syndrome in the bankruptcy case of opioid maker Purdue Pharma told a New York judge late Monday that the debtor's Chapter 11 plan documents don't provide enough information about their treatment.

  2. April 08, 2021

    Purdue Wants Another Month's Reprieve From Opioid Suits

    Purdue Pharma has asked a New York bankruptcy judge for another month of relief from lawsuits over its opioid sales, saying negotiations on the final form of its Chapter 11 plan are at a "critical stage."

  3. April 06, 2021

    Purdue Judge Wary Of Changing Reasons For Ch. 11 Probe

    A New York bankruptcy judge has asked a committee representing children allegedly injured by Purdue Pharma-made opioids to clarify why they are seeking a probe into OxyContin toxicology studies, saying its reasons have shifted since they first asked.

  4. March 24, 2021

    Purdue, Sackler Opioid Suits Paused For Another Month

    A New York bankruptcy judge on Wednesday granted Purdue Pharma and its former owners another month's relief from suits over Purdue's opioid sales, saying the continued pause will protect efforts to work out the details of the company's Chapter 11 plan.

  5. March 22, 2021

    States Say Time Has Come To Let Sackler Suits Proceed

    A group of states asked a New York bankruptcy judge Friday to deny Purdue Pharma's latest request to extend the injunction pausing their suits against the Sackler family, saying allowing their claims to go forward will create a better Chapter 11 plan.

  6. March 16, 2021

    Unhappy AGs Have Options In Latest Purdue Ch. 11 Plan

    The worst fears of state attorneys general materialized on Tuesday when Purdue Pharma LP and the Sackler family revealed the details of the company's Chapter 11 bankruptcy plan, with many states immediately declaring their "disappointment" about accountability and remedies for the deadliest drug crisis in the nation's history.

  7. March 16, 2021

    Purdue's Ch. 11 Plan Hangs On Sackler Liability Question

    The viability of Purdue Pharma's much anticipated Chapter 11 plan hangs on whether creditors are willing to release the Sackler family from what could be heaps of liability in exchange for their $4.5 billion in contributions that would fund creditor recoveries and opioid abatement programs, experts told Law360.

  8. March 16, 2021

    Purdue Files Ch. 11 Plan That Draws Criticism From State AGs

    OxyContin maker Purdue Pharma has filed its long-awaited Chapter 11 plan with a New York bankruptcy court under which its former owners have agreed to up their contributions to an opioid abatement trust fund to almost $4.3 billion, drawing immediate criticism from several state attorneys general that the plan still falls short.

  9. March 01, 2021

    Purdue Promises Ch. 11 Plan In 2 Weeks

    Purdue Pharma told a New York bankruptcy judge Monday it will have a Chapter 11 plan to present to the court within two weeks, although it couldn't say exactly what will emerge from ongoing talks between it and its creditors.

  10. February 17, 2021

    Sackler Family Can't Keep Names Of Its Businesses Secret

    A New York bankruptcy judge Wednesday ruled that the public has a right to see the names of businesses owned by members of Purdue Pharma's former owners, the Sackler family, saying the family had not backed its argument that this could open the companies to vandalism or worse.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!